{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:48:38Z","timestamp":1782391718807,"version":"3.54.5"},"reference-count":23,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Autour des Williams association","award":["SPARK-Tel Aviv and by Autour des Williams"],"award-info":[{"award-number":["SPARK-Tel Aviv and by Autour des Williams"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Child and Adolescent Psychopharmacology"],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Anxiety and depressive disorders are common in individuals with Williams syndrome (WS), yet data regarding pharmacologic treatment in this population are limited. This study aimed to evaluate the effectiveness and safety of selective serotonin reuptake inhibitors (SSRIs) in individuals with WS treated for anxiety and\/or depressive disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a retrospective chart review of patients with a genetically confirmed diagnosis of WS treated with SSRIs between 2010 and 2025 at a clinic for individuals with WS. Fourteen children and adults (5 males and 9 females; mean age: 23.2 \u00b1 11.9 years) met inclusion criteria, contributing 16 distinct SSRI treatment trials. Illness severity was assessed using the Clinical Global Impressions\u2013Severity (CGI-S) scale at baseline and last follow-up and the Clinical Global Impressions\u2013Improvement (CGI-I) scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The CGI-S score decreased significantly from 4.62 \u00b1 0.81 at baseline to 3.06 \u00b1 1.12 at last follow-up (\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      (15) = 3.83,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.002). Nine of 16 trials (56.2%) were rated as much or very much improved (CGI-I = 1 or 2). The mean duration of SSRI treatment was 3.95 \u00b1 3.91 years (range: 0.75\u201316). Adverse events were documented in two trials (12.5%), and no treatment discontinuations due to adverse events occurred.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>SSRI treatment was effective and well tolerated in individuals with WS. Prospective controlled studies are required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10445463261451798","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:11:41Z","timestamp":1778735501000},"page":"377-381","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness and Safety of Selective Serotonin Reuptake Inhibitors in Individuals with Williams Syndrome"],"prefix":"10.1177","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0496-1129","authenticated-orcid":false,"given":"Liron","family":"Snapir","sequence":"first","affiliation":[{"name":"The Department of Child and Adolescent Psychiatry, Behavioral Neurogenetics Center, Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center, Tel Hashomer, Israel."},{"name":"Gray Faculty of Medical &amp; Health Sciences, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Elazar","sequence":"additional","affiliation":[{"name":"The Department of Child and Adolescent Psychiatry, Behavioral Neurogenetics Center, Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center, Tel Hashomer, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Cohen","sequence":"additional","affiliation":[{"name":"The Department of Child and Adolescent Psychiatry, Behavioral Neurogenetics Center, Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center, Tel Hashomer, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronnie","family":"Weinberger","sequence":"additional","affiliation":[{"name":"The Department of Child and Adolescent Psychiatry, Behavioral Neurogenetics Center, Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center, Tel Hashomer, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Schwartz-Lifshitz","sequence":"additional","affiliation":[{"name":"The Department of Child and Adolescent Psychiatry, Behavioral Neurogenetics Center, Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center, Tel Hashomer, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Taler","sequence":"additional","affiliation":[{"name":"Gray Faculty of Medical &amp; Health Sciences, Tel Aviv University, Tel Aviv, Israel."},{"name":"Pediatric Molecular Psychiatry Laboratory, Sheba Medical Center, Tel Hashomer, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Gothelf","sequence":"additional","affiliation":[{"name":"The Department of Child and Adolescent Psychiatry, Behavioral Neurogenetics Center, Edmond and Lily Safra Children\u2019s Hospital, Sheba Medical Center, Tel Hashomer, Israel."},{"name":"Gray Faculty of Medical &amp; Health Sciences, Tel Aviv University, Tel Aviv, Israel."},{"name":"Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13r08672"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32802-7"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000000664"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/19315860902725867"},{"issue":"6","key":"e_1_3_6_7_1","first-page":"373","article-title":"Medical, cognitive, and psychiatric characteristics in a large Israeli cohort of individuals with Williams syndrome","volume":"20","author":"Dror C","year":"2018","unstructured":"Dror C, , Sinai A, , Gothelf D. Medical, cognitive, and psychiatric characteristics in a large Israeli cohort of individuals with Williams syndrome. Israel Med Assoc Journal : IMAJ 2018;20(6):373\u2013378.","journal-title":"Israel Med Assoc Journal : IMAJ"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/87565641.2003.9651896"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000196643.35395.5f"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.31247"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1037\/e591322011-001"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11689-009-9003-1"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.30344"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2012.06.006"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0903074"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-016-2909-z"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2024.2308678"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1352\/1944-7558-115.1.3"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.22329"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-019-04301-9"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1867535"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2024.0124"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804633"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2013.07.001"}],"container-title":["Journal of Child and Adolescent Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10445463261451798","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10445463261451798","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10445463261451798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:49:37Z","timestamp":1782388177000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10445463261451798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8,1]]}},"alternative-id":["10.1177\/10445463261451798"],"URL":"https:\/\/doi.org\/10.1177\/10445463261451798","relation":{},"ISSN":["1044-5463","1557-8992"],"issn-type":[{"value":"1044-5463","type":"print"},{"value":"1557-8992","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]}}}